USP22 and breast cancer: Furthermore, we identified that USP22 mRNA and protein levels in TNBC and HER2+-BC biopsies, the two most challenging BC subtypes, are highly correlated with a stemness signature (Fig. 2B-C) and poor survival outcome (Fig. 2D-F).